Author: Dr. Artur Reis
Dr. Artur Reis– Specialist in Peritoneal Surface Oncology, certified by the European Society of Surgical Oncology (ESSO). With expertise in Cytoreductive Surgery with HIPEC and PIPAC, Dr. Reis is committed to advancing surgical oncology through research, education, and innovation. As the curator of P.life Papers, he bridges the gap between clinical practice and scientific knowledge, ensuring that oncology professionals have access to cutting-edge research and best practices. He is the Director of the Specialized Center for Peritoneal Surface Oncology at Santa Casa de São José dos Campos and the Director of the Peritoneal Oncology Center at Hospital Rede D'Or Vivalle. Registered medical doctor with the Brazilian Medical Council (CRM-SP: 124.285/ RQE:41.487).
Ethical notice: This article is for educational purposes only and does not replace medical advice. If you have persistent symptoms,…
Ethical notice: This article is for educational purposes only and does not replace medical advice. Treatment decisions must be individualized.…
Incidental peritoneal metastases discovered during emergency surgery represent a critical decision point. Key Takeaways Watch the video summary (NotebookLM): https://youtu.be/XXkFm_0_zeoListen…
The Care Pathway Revolution in Peritoneal Surface Oncology Introduction: When the paradigm truly shifts For decades, a diagnosis of Peritoneal…
Intestinal transplantation pseudomyxoma peritonei Yesterday, I had the honor of serving as both moderator and speaker at the Pre-Congress Course…
📍 P.life Papers | July 2025 Exercise after chemotherapy for colon cancer🎙️ Based on the podcast episode “Exercise as Treatment”📚…
Title of Study: The biological basis and function of GNAS mutation in pseudomyxoma peritonei: a reviewAuthors: Yu-Lin Lin, Ru Ma,…
Immunotherapy in pseudomyxoma peritonei. Study Title: Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritoneiPublished In: Cancer Biology…
GNAS Mutation in Pseudomyxoma Peritonei: How One Gene Drives Mucin Secretion and Shapes Treatment PotentialDive into the molecular biology of…
HIPEC for recurrent ovarian cancer. Study Title: Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3…